FDA approves new GENE THERAPY for rare skin disease
Apr 30th 2025 2:00am EDT

(NaturalNews) On April 29, the U.S. Food and Drug Administration authorized Zevaskyn, a first-of-its-kind gene therapy for recessive dystrophic epidermolysis…
Discuss on Nostr!
Nostr Note ID note167zu6hzq8lprjd8mklrgjmw6a4z5xll8443ap3hmajuclj3yy6xqf97esu Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.
